SCOPE - Single-Point Classification Observational Peristomal Evaluation
Launched by CONVATEC INC. · Sep 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SCOPE trial is a study designed to better understand skin health around ostomies, which are openings created in the body for waste removal, including ileostomies, colostomies, and urostomies. Researchers will collect photos of these stomas (the part of the body where the waste comes out) to compare the images and evaluate skin conditions digitally instead of just through in-person visits. This could help improve care for people with ostomies.
To be eligible for this study, participants must be at least 18 years old and have an ileostomy, colostomy, or urostomy. They also need to be willing to provide consent to participate. However, individuals with two or more ostomies or specific complications related to their stomas, like enterocutaneous fistulae, won't be able to join. Although the study is not yet recruiting participants, it aims to gather important information that could lead to better management and care for people with these types of surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with ileostomy, colostomy or urostomy
- • Age ≥ 18 years of age
- • Able and willing to provide informed consent
- Exclusion Criteria:
- • Enterocutaneous fistulae
- • Patients with two or more ostomies
About Convatec Inc.
ConvaTec Inc. is a global medical technology company dedicated to the development and commercialization of innovative products and solutions for the management of chronic and acute medical conditions. With a focus on advanced wound care, ostomy care, continence and critical care, and infusion devices, ConvaTec aims to enhance the quality of life for patients through evidence-based practices and cutting-edge research. The company is committed to clinical excellence and actively sponsors clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of healthcare delivery and patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bogotá, , Colombia
Medellín, , Colombia
São Paulo, , Brazil
São Paulo, , Brazil
Bogotá, , Colombia
Medellín, , Colombia
Patients applied
Trial Officials
Sandra Guerrero, MD
Principal Investigator
Principal Investigator Colombia
Maria Angela Boccara de Paula, PhD
Principal Investigator
Principal Investigator Brazil
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported